Evidence map›Paper›PMID 33420479›Full record

ArticleMolecular psychiatry2021

Striatal dopamine D

Nicole Petersen, Andrea J Rapkin, Kyoji Okita, Kaitlin R Kinney, Tomi Mizuno, Mark A Mandelkern, Edythe D London

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Nicole PetersenJane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, 90095, USA. npetersen@ucla.edu.
Andrea J RapkinDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Kyoji OkitaDepartment of Clinical Neuroimaging, Integrative Brain Imaging Center, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8551, Japan.
Kaitlin R KinneyJane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, 90095, USA.
Tomi MizunoJane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, 90095, USA.
Mark A MandelkernVeterans Administration of Greater Los Angeles Health System, Los Angeles, CA, 90073, USA.
Edythe D LondonJane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, 90095, USA. elondon@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-3577-7808
Neurobehavioral Systems · USUCLA Health · USNational Center of Neurology and Psychiatry · JPUniversity of California, Irvine · USUniversity of California, Los Angeles · US

Funding

Transcranial Magnetic Stimulation and Tobacco Use Disorder: A Network-Level Approach with Attention to Sex as a Biological VariableR00DA045749 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PETERSEN, NICOLE · 2021 to 2023
$902k
Estrogen, dopamine D2-type receptors, and self-controlF32DA039715 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PETERSEN, NICOLE · 2015 to 2017
$113k
NIDA NIH HHS F32 DA039715NIDA NIH HHS R00 DA045749
6 · The paper itself

Abstract

Research using rodent models has established a relationship between the steroid hormone estrogen and dopamine function, by revealing changes throughout the estrous cycle and by directly manipulating neuroendocrine signaling through ovariectomy and administration of estrogen. However, a direct link between estrogen levels and dopamine signaling had not been established in humans. The goal of this study, therefore, was to assess the relationship between circulating 17β-estradiol and dopamine signaling in the human brain by testing for a relationship between two proxies for these variables: peripheral 17β-estradiol and striatal dopamine D

Indexed as

DopamineReceptors, Dopamine D2Corpus StriatumEstradiolFemaleHumansPositron-Emission TomographyReceptors, Dopamine D3DopamineEstradiolReceptors, Dopamine D2Receptors, Dopamine D3

Identifiers

PMID33420479
PMCPMC9196143
OpenAlexW3119781845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.